Published in J Clin Psychiatry on May 18, 2010
Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol (2014) 1.23
Perceived Stress in Obsessive-Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms. Front Psychiatry (2013) 0.83
Ovarian Sex Hormones Modulate Compulsive, Affective and Cognitive Functions in A Non-Induced Mouse Model of Obsessive-Compulsive Disorder. Front Behav Neurosci (2016) 0.75
DNA Methylation at the Neonatal State and at the Time of Diagnosis: Preliminary Support for an Association with the Estrogen Receptor 1, Gamma-Aminobutyric Acid B Receptor 1, and Myelin Oligodendrocyte Glycoprotein in Female Adolescent Patients with OCD. Front Psychiatry (2016) 0.75
Obsessive-compulsive disorder in pregnancy and the postpartum period: course of illness and obstetrical outcome. Arch Womens Ment Health (2015) 0.75
Reproductive hormone sensitivity and obsessive-compulsive disorder: are there differences in the genetic predisposition between symptom dimensions? J Clin Psychiatry (2011) 0.75
Stress response in postpartum women with and without obsessive-compulsive symptoms: an fMRI study. J Psychiatry Neurosci (2012) 0.75
Pregnancy is associated with psychiatric symptoms in a low-income countryside community of Brazil. Neuropsychiatr Dis Treat (2011) 0.75
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science (1999) 6.24
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry (2008) 3.81
New parents and mental disorders: a population-based register study. JAMA (2006) 3.52
Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci U S A (1979) 2.43
Implications of attachment theory for developmental psychopathology. Dev Psychopathol (1999) 2.00
Hormones and mood: from menarche to menopause and beyond. J Affect Disord (2003) 1.99
The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry (1993) 1.87
Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry (1992) 1.75
Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry (2002) 1.33
Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry (1996) 1.18
Prospective study into puerperal depression. Br J Psychiatry (1971) 1.17
Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry (1994) 1.14
Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry (1997) 1.13
A follow-up study of obsessional neurotics in Hong Kong Chinese. Br J Psychiatry (1967) 1.09
Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. J Anxiety Disord (2003) 1.09
Risk factors associated with the development of postpartum mood disorders. J Affect Disord (2005) 1.08
Thoughts of harming infants in depressed and nondepressed mothers. J Affect Disord (1999) 1.06
Epidemiology of obsessive compulsive disorder. J Clin Psychiatry (1990) 1.05
Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry (2005) 1.02
Regulation of neuronal oxytocin mRNA by ovarian steroids in the mature and developing hypothalamus. Proc Natl Acad Sci U S A (1989) 1.01
The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology (1994) 0.98
Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry Res (1999) 0.97
Postpartum obsessive compulsive disorder: a case series. J Clin Psychiatry (1993) 0.95
Preoccupations and behaviors associated with romantic and parental love. Perspectives on the origin of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am (1999) 0.93
Postpartum onset of obsessive-compulsive disorder. Psychosomatics (1993) 0.89
Obsessive-compulsive disorder in pregnant women during the third trimester of pregnancy. Compr Psychiatry (2007) 0.86
Gender in obsessive-compulsive disorder: clinical and genetic findings. Eur Neuropsychopharmacol (2004) 0.86
Obsessional illness in mental hospital patients. J Ment Sci (1961) 0.83
Recent developments in neurobiology of obsessive-compulsive disorder. J Clin Psychiatry (1996) 0.80
Obsessive-compulsive disorder limited to pregnancy. Psychother Psychosom (1995) 0.79
A Case Series of Women With Postpartum-Onset Obsessive-Compulsive Disorder. Prim Care Companion J Clin Psychiatry (1999) 0.79
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry (2004) 3.64
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol (2007) 1.98
Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res (2005) 1.94
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol (2009) 1.90
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res (2011) 1.80
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Normalizing effects of modafinil on sleep in chronic cocaine users. Am J Psychiatry (2010) 1.73
Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry (2006) 1.71
Validity of the autism diagnostic interview-revised. Am J Ment Retard (2006) 1.66
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61
Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial. Biol Psychiatry (2013) 1.57
Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics (2003) 1.56
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55
Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder. Bipolar Disord (2005) 1.47
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord (2008) 1.46
A meta-analysis of treatments for perinatal depression. Clin Psychol Rev (2011) 1.43
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry (2007) 1.42
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry (2004) 1.40
Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin Cancer Res (2004) 1.37
Functional connectivity between ventral prefrontal cortex and amygdala at low frequency in the resting state in bipolar disorder. Psychiatry Res (2010) 1.35
Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev (2005) 1.34
Relation between amygdala structure and function in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.33
Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia. Biol Psychiatry (2010) 1.29
Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Paediatr Drugs (2004) 1.26
Abnormal corpus callosum integrity in bipolar disorder: a diffusion tensor imaging study. Biol Psychiatry (2008) 1.24
Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol (2005) 1.24
Structural and functional magnetic resonance imaging of autism spectrum disorders. Brain Res (2010) 1.22
A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol (2004) 1.20
Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) (2013) 1.19
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry (2006) 1.18
High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry (2004) 1.18
A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) (2006) 1.18
Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry (2007) 1.17
Relapse of major depression in women who continue or discontinue antidepressant medication during pregnancy. Am J Psychiatry (2013) 1.16
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry (2004) 1.16
Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. Br J Psychiatry (2007) 1.16
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol (2010) 1.15
Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol (2004) 1.15
Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol (2002) 1.13
New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials. Biol Psychiatry (2007) 1.12
Pharmacotherapy to control behavioral symptoms in children with autism. Expert Opin Pharmacother (2012) 1.12
Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp (2012) 1.12
Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am (2008) 1.10
Utilization and barriers to mental health services among depressed medical interns: a prospective multisite study. J Grad Med Educ (2010) 1.10
Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry (2005) 1.10
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health (2011) 1.09
Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol (2004) 1.09
Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology (2007) 1.08
Role of variation in the serotonin transporter protein gene (SLC6A4) in trait disturbances in the ventral anterior cingulate in bipolar disorder. Neuropsychopharmacology (2008) 1.08
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase. J Nucl Med (2007) 1.08
Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology (2002) 1.08
High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry (2003) 1.07
Maternal folic acid supplementation and risk of autism. JAMA (2013) 1.07
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.07
Pharmacologic treatment of autism and related disorders. Pediatr Ann (2007) 1.07
An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry (2002) 1.06
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. J Child Adolesc Psychopharmacol (2009) 1.06
Antipsychotics in the treatment of autism. J Clin Invest (2008) 1.06
Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology (2008) 1.05
The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav (2002) 1.05
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry (2011) 1.05
Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry (2011) 1.04
Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors. Anticancer Res (2002) 1.04
Open-label memantine in fragile X syndrome. J Autism Dev Disord (2009) 1.04
Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage (2006) 1.04
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biol Psychiatry (2012) 1.04
The use of selective serotonin reuptake inhibitors in autism and related disorders. J Child Adolesc Psychopharmacol (2006) 1.04
The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology (2012) 1.03
Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res (2007) 1.03
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl) (2008) 1.03
Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Curr Treat Options Neurol (2010) 1.02
Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord (2013) 1.02
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 1.02
Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans. Neuropsychopharmacology (2012) 1.01
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry (2007) 1.00
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today (2008) 1.00
Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord (2005) 1.00
Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord (2004) 0.99
Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse. Nutr Cancer (2003) 0.99
Brief report: acamprosate in fragile X syndrome. J Autism Dev Disord (2010) 0.99
Elevated risk of adverse obstetric outcomes in pregnant women with depression. Arch Womens Ment Health (2013) 0.99
Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole. J Child Adolesc Psychopharmacol (2014) 0.99
Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans. J Nucl Med (2012) 0.98
Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women. Addict Biol (2008) 0.98
Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. J Autism Dev Disord (2013) 0.98
Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach. J Autism Dev Disord (2015) 0.97
Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. Am J Psychiatry (2012) 0.97
Citalopram reduces endotoxin-induced fatigue. Brain Behav Immun (2010) 0.97
Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. J Autism Dev Disord (2008) 0.96
Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev (2003) 0.96
Prenatal programming of mental illness: current understanding of relationship and mechanisms. Curr Psychiatry Rep (2015) 0.96
Increased brain uptake and oxidation of acetate in heavy drinkers. J Clin Invest (2013) 0.95
Changes in the diagnostic criteria for autism in DSM-5: controversies and concerns. J Clin Psychiatry (2013) 0.95